Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Lawrence Rosen / Aldeyra Therapeutics

Lawrence Rosen & Aldeyra Therapeutics

1 shared events · Importance 3 · Last updated May 12, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
26.666666666666668
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (1)
63
Regulatory
Aldeyra Therapeutics Securities Fraud Lawsuit
Lawrence Rosen: Lawrence Rosen is a founding partner of Rosen Law Firm, which is leading the securities class action against Aldeyra Therapeutics.
Aldeyra Therapeutics: Aldeyra Therapeutics is the defendant in a securities class action lawsuit, accused of making false and misleading statements regarding its reproxalap clinical trials, which could lead to significant financial damages.
May 03, 2026 · 8 articles
NEWSDESK
Explore this relationship live

Track how Lawrence Rosen and Aldeyra Therapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.